Description
Trizipin (meldonium) Solution for Injections 100 mg/ml – 5 ml Vials №10
Ingredients:
- Each 5 ml vial contains 500 mg of meldonium as the active ingredient.
Dosage:
- The usual dose ranges from 500 mg to 1000 mg per day, administered intravenously. Dosage may vary depending on the specific condition being treated.
Indications:
- Trizipin (meldonium) is indicated for the treatment of angina, heart failure, and ischemic heart disease.
Contraindications:
- Avoid using Trizipin (meldonium) if you have severe liver or kidney disease.
Directions:
- Administer Trizipin (meldonium) intravenously and adhere to the prescribed dosage instructions provided by your healthcare provider.
Scientific Evidence:
- Research indicates that meldonium, the active ingredient in Trizipin, exhibits cardioprotective effects by enhancing energy metabolism and reducing oxidative stress in cardiac cells. Studies by Serebruany et al. (2017) have shown the efficacy of meldonium in enhancing exercise capacity in patients with chronic heart failure.
Additional Information:
- Trizipin (meldonium) has garnered attention in the sports community for its potential performance-enhancing properties. However, its use in competitive sports is banned by the World Anti-Doping Agency (WADA) due to concerns regarding unfair advantages.
- It is crucial to seek guidance from a healthcare professional before using Trizipin (meldonium) to determine the suitable dosage and ensure its safety and appropriateness for your medical condition.